Author

Philip A. Gurnev

National Institutes of HealthORCID 0000-0001-9247-5027Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

David P. HoogerheideiD· 1 shared Sergey M. BezrukoviD· 1 shared Tatiana K. RostovtsevaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

David P. HoogerheideORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiophysicsbioRxivPreprintOct 19, 2026

Towards VDAC pharmacology: Developing small-peptide channel inhibitors inspired by nature

Tatiana K. Rostovtseva, Philip A. Gurnev, David P. Hoogerheide, Sergey M. Bezrukov

This study develops small-peptide inhibitors of VDAC inspired by natural proteins, showing they can block the channel in lipid membranes, though with lower potency than the natural inhibitor Syn.

DOI 10.64898/2026.10.13.758907

experimental assaydrug response / drug discovery

𝕏 PostBluesky